BPH Global Ltd's Framework Supply Agreement with Guangzhou Xiaoliwu

BPH Global Ltd (ASX: $BP8) has announced that its subsidiary Foshan Gedishi Biotechnology Co Ltd has entered into a framework supply agreement with Guangzhou Xiaoliwu for the supply of bird's nest products to be sold in the Chinese market. This achievement marks a key component of the company's 120-day business plan.

Executive Commentary on Business Development Plan

The Company's ability to secure the supply of quality bird's nest products at competitive prices underpins its goal of growing its bird's nest products sales numbers in China. The Guangzhou Xiaoliwu Supply Agreement will be leveraged to acquire bird's nest products in preparation for major selling opportunities, including the Chinese Autumn Festival and corporate gift programs with major Chinese banks.

Summary of BPH Global's Expansion Strategy

BPH Global Ltd's framework supply agreement with Guangzhou Xiaoliwu signifies a significant milestone in the company's 120-day business plan, aiming to expand its bird's nest product sales in China. The agreement will underpin the company's further expansion of sales and distribution channels for bird's nest products in China. Leveraging this agreement, the company is preparing for upcoming selling opportunities, including the Chinese Autumn Festival and corporate gift programs with major Chinese banks. The Board regards this 120-day plan as a driver of short-term growth in sales of bird's nest products and is looking forward to the ongoing expansion of the company's business operations.